Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Alfred E Buxton, M.D.

Title
Institution
Department
Address
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. U01HL045700 (BUXTON, ALFRED E) Sep 30, 1991 - Feb 29, 2000
    NIH
    NONSUSTAINED VENTRICULAR TACHYCARDIA
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Katritsis DG, Marine JE, Katritsis G, Latchamsetty R, Zografos T, Zimetbaum P, Buxton AE, Calkins H, Morady F, Sánchez-Quintana D, Anderson RH. Spatial characterization of the tachycardia circuit of atrioventricular nodal re-entrant tachycardia. Europace. 2021 10 09; 23(10):1596-1602. PMID: 34240123.
    Citations:    Fields:    Translation:Humans
  2. Raber I, Matos JD, Buxton AE. Wide Complex Tachycardia in a Young Woman. JACC Case Rep. 2021 Sep 01; 3(11):1357-1359. PMID: 34505069.
    Citations:    
  3. Buxton AE, Locke AH, Miller JM, D'Avila A, Marchlinski FE. Thirty years of catheter ablation for ventricular tachycardia. Heart Rhythm. 2021 Jun; 18(6):1033-1034. PMID: 34059227.
    Citations:    Fields:    
  4. Tung P, Waks JW, Sehgal S, Buxton AE, D'Avila A. Hemodynamic intolerance and pericardial effusion associated with high-frequency jet ventilation during pulmonary vein isolation. Heart Rhythm O2. 2021 Aug; 2(4):341-346. PMID: 34430939.
    Citations:    
  5. Serber ER, Christon LM, Fava JL, Verrier RL, Nearing BD, Buxton AE, Gold MR, Rodrigue JR, Frisch MB. Positive Psychotherapy Improves Cardiac Electrical Stability and Mood in ICD Patients: PAM-ICD Trial Results. Psychosom Med. 2021 04 01; 83(3):300-301. PMID: 33534391.
    Citations:    Fields:    Translation:Humans
  6. Sroubek J, Matos J, Locke A, Kaplinskiy V, Levine YC, Shen C, Buxton AE. N-terminal pro-B-type natriuretic peptide is a specific predictor of appropriate device therapies in patients with primary prevention implantable cardioverter-defibrillators. Heart Rhythm. 2021 01; 18(1):71-78. PMID: 32866691.
    Citations:    Fields:    
  7. Stabenau HF, Shen C, Zimetbaum P, Buxton AE, Tereshchenko LG, Waks JW. Global electrical heterogeneity associated with drug-induced torsades de pointes. Heart Rhythm. 2021 01; 18(1):57-62. PMID: 32781158.
    Citations: 2     Fields:    
  8. Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Europace. 2020 08 01; 22(8):1147-1148. PMID: 32538434.
    Citations: 13     Fields:    Translation:Humans
  9. Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, Lim HS, Lip GYH, Nava-Townsend S, Pak HN, Diez GR, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Pava Molano LF, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. Heart Rhythm. 2020 09; 17(9):e269-e316. PMID: 32553607.
    Citations: 2     Fields:    Translation:Humans
  10. Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, Sepehri Shamloo A, Alfie A, Boveda S, Dagres N, Di Toro D, Eckhardt LL, Ellenbogen K, Hardy C, Ikeda T, Jaswal A, Kaufman E, Krahn A, Kusano K, Kutyifa V, S Lim H, Lip GYH, Nava-Townsend S, Pak HN, Rodríguez Diez G, Sauer W, Saxena A, Svendsen JH, Vanegas D, Vaseghi M, Wilde A, Bunch TJ, Buxton AE, Calvimontes G, Chao TF, Eckardt L, Estner H, Gillis AM, Isa R, Kautzner J, Maury P, Moss JD, Nam GB, Olshansky B, Molano LFP, Pimentel M, Prabhu M, Tzou WS, Sommer P, Swampillai J, Vidal A, Deneke T, Hindricks G, Leclercq C. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population. J Arrhythm. 2020 Aug; 36(4):553-607. PMID: 32782627.
    Citations: 6     
  11. Anter E, Neuzil P, Reddy VY, Petru J, Park KM, Sroubek J, Leshem E, Zimetbaum PJ, Buxton AE, Kleber AG, Shen C, Wit AL. Ablation of Reentry-Vulnerable Zones Determined by Left Ventricular Activation From Multiple Directions: A Novel Approach for Ventricular Tachycardia Ablation: A Multicenter Study (PHYSIO-VT). Circ Arrhythm Electrophysiol. 2020 06; 13(6):e008625. PMID: 32372657.
    Citations: 3     Fields:    Translation:Humans
  12. Al-Khatib SM, Benjamin EJ, Buxton AE, Calkins H, Chung MK, Curtis AB, Desvigne-Nickens P, Jais P, Packer DL, Piccini JP, Rosenberg Y, Russo AM, Wang PJ, Cooper LS, Go AS. Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Circulation. 2020 02 11; 141(6):482-492. PMID: 31744331.
    Citations: 10     Fields:    Translation:Humans
  13. Leshem E, Zilberman I, Barkagan M, Shapira-Daniels A, Sroubek J, Govari A, Buxton AE, Anter E. Temperature-Controlled Radiofrequency Ablation Using Irrigated Catheters: Maximizing Ventricular Lesion Dimensions While Reducing Steam-Pop Formation. JACC Clin Electrophysiol. 2020 01; 6(1):83-93. PMID: 31971910.
    Citations: 2     Fields:    Translation:Animals
  14. Rottmann M, Kleber AG, Barkagan M, Sroubek J, Leshem E, Shapira-Daniels A, Buxton AE, Anter E. Activation During Sinus Rhythm in Ventricles With Healed Infarction: Differentiation Between Arrhythmogenic and Nonarrhythmogenic Scar. Circ Arrhythm Electrophysiol. 2019 10; 12(10):e007879. PMID: 31597477.
    Citations: 1     Fields:    Translation:Animals
  15. Kramer DB, Buxton AE, Zimetbaum PJ. Conversion, Compromise, and Conversation-Moving to a Sensible Middle When Addressing Implantable Cardioverter-Defibrillator Therapy-Reply. JAMA Cardiol. 2019 10 01; 4(10):1049-1050. PMID: 31365023.
    Citations:    Fields:    Translation:Humans
  16. Reeder HT, Shen C, Buxton AE, Haneuse SJ, Kramer DB. Joint Shock/Death Risk Prediction Model for Patients Considering Implantable Cardioverter-Defibrillators. Circ Cardiovasc Qual Outcomes. 2019 08; 12(8):e005675. PMID: 31412732.
    Citations: 1     Fields:    Translation:Humans
  17. Amin MM, Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Hodge DO, Frey RJ, Frederick NK, Cha YM, Brenes-Salazar J, Madhavan M. Association between the Charlson comorbidity index and outcomes after implantable cardioverter defibrillator generator replacement. Pacing Clin Electrophysiol. 2019 09; 42(9):1236-1242. PMID: 31355952.
    Citations: 1     Fields:    Translation:Humans
  18. Barkagan M, Leshem E, Shapira-Daniels A, Sroubek J, Buxton AE, Saffitz JE, Anter E. Histopathological Characterization of Radiofrequency Ablation in Ventricular Scar Tissue. JACC Clin Electrophysiol. 2019 08; 5(8):920-931. PMID: 31439293.
    Citations: 7     Fields:    Translation:Animals
  19. Shapira-Daniels A, Barkagan M, Rottmann M, Sroubek J, Tugal D, Carlozzi MA, McConville JW, Buxton AE, Anter E. Modulating the Baseline Impedance: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate: An Adjunctive Technique for Maximizing Radiofrequency Lesion Dimensions in Deep and Intramural Ventricular Substrate. Circ Arrhythm Electrophysiol. 2019 06; 12(6):e007336. PMID: 31113232.
    Citations: 3     Fields:    Translation:Humans
  20. Kramer DB, Buxton AE, Zimetbaum PJ. Facilitating Conversion of Implantable Cardioverter-Defibrillator Therapy to Pacing Only-Time to Adapt. JAMA Cardiol. 2019 05 01; 4(5):401-402. PMID: 30994859.
    Citations:    Fields:    Translation:Humans
  21. Sroubek J, Tugal D, Zimetbaum PJ, Shvilkin A, Buxton AE. Treatment of painful left bundle branch block syndrome with cardiac resynchronization therapy or right-ventricular pacing. HeartRhythm Case Rep. 2019 Jun; 5(6):321-324. PMID: 31285990.
    Citations: 2     
  22. Barkagan M, Rottmann M, Leshem E, Shen C, Buxton AE, Anter E. Effect of Baseline Impedance on Ablation Lesion Dimensions: A Multimodality Concept Validation From Physics to Clinical Experience. Circ Arrhythm Electrophysiol. 2018 10; 11(10):e006690. PMID: 30354405.
    Citations: 9     Fields:    Translation:Animals
  23. Olgin JE, Pletcher MJ, Vittinghoff E, Wranicz J, Malik R, Morin DP, Zweibel S, Buxton AE, Elayi CS, Chung EH, Rashba E, Borggrefe M, Hue TF, Maguire C, Lin F, Simon JA, Hulley S, Lee BK. Wearable Cardioverter-Defibrillator after Myocardial Infarction. N Engl J Med. 2018 Sep 27; 379(13):1205-1215. PMID: 30280654.
    Citations: 46     Fields:    Translation:Humans
  24. Huikuri H, Buxton AE. Identification of suitable patients for ICD therapy. Int J Cardiol. 2018 12 01; 272:217-218. PMID: 30131232.
    Citations:    Fields:    Translation:Humans
  25. Witt CM, Waks JW, Mehta RA, Friedman PA, Kramer DB, Buxton AE, Mulpuru SK, Noseworthy PA, Hodge DO, Lushinsky EC, Mulholland MB, Cha YM, Gersh BJ, Madhavan M. Risk of Appropriate Therapy and Death Before Therapy After Implantable Cardioverter-Defibrillator Generator Replacement. Circ Arrhythm Electrophysiol. 2018 08; 11(8):e006155. PMID: 30354311.
    Citations: 5     Fields:    Translation:Humans
  26. Anter E, Duytschaever M, Shen C, Strisciuglio T, Leshem E, Contreras-Valdes FM, Waks JW, Zimetbaum PJ, Kumar K, Spector PS, Lee A, Gerstenfeld EP, Nakar E, Bar-Tal M, Buxton AE. Activation Mapping With Integration of Vector and Velocity Information Improves the Ability to Identify the Mechanism and Location of Complex Scar-Related Atrial Tachycardias. Circ Arrhythm Electrophysiol. 2018 08; 11(8):e006536. PMID: 30354312.
    Citations: 6     Fields:    Translation:Humans
  27. Desai NR, Bourdillon PM, Parzynski CS, Brindis RG, Spatz ES, Masters C, Minges KE, Peterson P, Masoudi FA, Oetgen WJ, Buxton A, Zipes DP, Curtis JP. Association of the US Department of Justice Investigation of Implantable Cardioverter-Defibrillators and Devices Not Meeting the Medicare National Coverage Determination, 2007-2015. JAMA. 2018 07 03; 320(1):63-71. PMID: 29971398.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  28. Anter E, Kleber AG, Rottmann M, Leshem E, Barkagan M, Tschabrunn CM, Contreras-Valdes FM, Buxton AE. Infarct-Related Ventricular Tachycardia: Redefining the Electrophysiological Substrate of the Isthmus During Sinus Rhythm. JACC Clin Electrophysiol. 2018 08; 4(8):1033-1048. PMID: 30139485.
    Citations: 17     Fields:    Translation:Animals
  29. Barkagan M, Contreras-Valdes FM, Leshem E, Buxton AE, Nakagawa H, Anter E. High-power and short-duration ablation for pulmonary vein isolation: Safety, efficacy, and long-term durability. J Cardiovasc Electrophysiol. 2018 09; 29(9):1287-1296. PMID: 29846987.
    Citations: 17     Fields:    Translation:Animals
  30. Malik M, Buxton AE, Huikuri H, Lombardi F, Schmidt G, Zabel M. Noninvasive electrophysiology in risk assessment and screening. Heart Rhythm. 2018 06; 15(6):803-804. PMID: 29857851.
    Citations: 2     Fields:    
  31. Sharma A, Al-Khatib SM, Ezekowitz JA, Cooper LB, Fordyce CB, Michael Felker G, Bardy GH, Poole JE, Thomas Bigger J, Buxton AE, Moss AJ, Friedman DJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Peterson ED, Inoue LYT, Sanders GD. Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes. Eur J Heart Fail. 2018 06; 20(6):1031-1038. PMID: 29761861.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  32. Tereshchenko LG, Sotoodehnia N, Sitlani CM, Ashar FN, Kabir M, Biggs ML, Morley MP, Waks JW, Soliman EZ, Buxton AE, Biering-Sørensen T, Solomon SD, Post WS, Cappola TP, Siscovick DS, Arking DE. Genome-Wide Associations of Global Electrical Heterogeneity ECG Phenotype: The ARIC (Atherosclerosis Risk in Communities) Study and CHS (Cardiovascular Health Study). J Am Heart Assoc. 2018 04 05; 7(8). PMID: 29622589.
    Citations: 14     Fields:    Translation:Humans
  33. Biering-Sørensen T, Kabir M, Waks JW, Thomas J, Post WS, Soliman EZ, Buxton AE, Shah AM, Solomon SD, Tereshchenko LG. Global ECG Measures and Cardiac Structure and Function: The ARIC Study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2018 03; 11(3):e005961. PMID: 29496680.
    Citations: 10     Fields:    Translation:Humans
  34. Waks JW, Buxton AE. Risk Stratification for Sudden Cardiac Death After Myocardial Infarction. Annu Rev Med. 2018 01 29; 69:147-164. PMID: 29414264.
    Citations: 6     Fields:    Translation:Humans
  35. Adabag S, Patton KK, Buxton AE. Benefits of Contemporary Implantable Cardioverter Defibrillators in Patients With Improved Ejection Fraction: When is the Most Clinically Relevant Time to Evaluate?-Reply. JAMA Cardiol. 2017 12 01; 2(12):1397-1398. PMID: 28973098.
    Citations:    Fields:    Translation:Humans
  36. Anter E, Di Biase L, Contreras-Valdes FM, Gianni C, Mohanty S, Tschabrunn CM, Viles-Gonzalez JF, Leshem E, Buxton AE, Kulbak G, Halaby RN, Zimetbaum PJ, Waks JW, Thomas RJ, Natale A, Josephson ME. Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea. Circ Arrhythm Electrophysiol. 2017 Nov; 10(11). PMID: 29133380.
    Citations: 13     Fields:    Translation:Humans
  37. Sroubek J, Buxton AE. Primary Prevention Implantable Cardiac Defibrillator Trials: What Have We Learned? Card Electrophysiol Clin. 2017 12; 9(4):761-773. PMID: 29173416.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  38. Zeitler EP, Al-Khatib SM, Friedman DJ, Han JY, Poole JE, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II. J Cardiovasc Electrophysiol. 2017 Nov; 28(11):1345-1351. PMID: 28744959.
    Citations: 3     Fields:    Translation:Humans
  39. Adabag S, Patton KK, Buxton AE, Rector TS, Ensrud KE, Vakil K, Levy WC, Poole JE. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial. JAMA Cardiol. 2017 07 01; 2(7):767-774. PMID: 28724134.
    Citations: 10     Fields:    Translation:Humans
  40. Friedman DJ, Al-Khatib SM, Zeitler EP, Han J, Bardy GH, Poole JE, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LYT, Sanders GD. New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials. Am Heart J. 2017 Sep; 191:21-29. PMID: 28888266.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  41. Shenasa M, Miller JM, Callans DJ, Almendral JM, Marchlinski FE, Buxton AE. Conquest of Ventricular Tachycardia: Insights Into Mechanisms, Innovations in Management: Contribution of Mark E. Josephson, MD, to Clinical Electrophysiology. Circ Arrhythm Electrophysiol. 2017 05; 10(5). PMID: 28487348.
    Citations: 1     Fields:    Translation:Humans
  42. Buxton A. "What Would He Do Next?" Arrhythm Electrophysiol Rev. 2017 Apr; 6(1):13. PMID: 28507739.
    Citations:    
  43. Buxton AE. Sudden death in ischemic heart disease - 2017. Int J Cardiol. 2017 Jun 15; 237:64-66. PMID: 28365181.
    Citations: 3     Fields:    Translation:Humans
  44. Katritsis DG, Marine JE, Contreras FM, Fujii A, Latchamsetty R, Siontis KC, Katritsis GD, Zografos T, John RM, Epstein LM, Michaud GF, Anter E, Sepahpour A, Rowland E, Buxton AE, Calkins H, Morady F, Stevenson WG, Josephson ME. Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia. Circulation. 2016 Nov 22; 134(21):1655-1663. PMID: 27754882.
    Citations: 5     Fields:    Translation:Humans
  45. Buxton AE, Waks JW, Shen C, Chen PS. Risk stratification for sudden cardiac death in North America - current perspectives. J Electrocardiol. 2016 Nov - Dec; 49(6):817-823. PMID: 27524476.
    Citations: 2     Fields:    Translation:Humans
  46. Anter E, Tschabrunn CM, Buxton AE, Josephson ME. High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit. Circulation. 2016 Jul 26; 134(4):314-27. PMID: 27440005.
    Citations: 40     Fields:    Translation:Animals
  47. Shen C, Hu Y, Li X, Wang Y, Chen PS, Buxton AE. Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree. Biom J. 2016 Nov; 58(6):1357-1375. PMID: 27356196.
    Citations: 1     Fields:    Translation:Humans
  48. Waks JW, Sitlani CM, Soliman EZ, Kabir M, Ghafoori E, Biggs ML, Henrikson CA, Sotoodehnia N, Biering-Sørensen T, Agarwal SK, Siscovick DS, Post WS, Solomon SD, Buxton AE, Josephson ME, Tereshchenko LG. Global Electric Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Circulation. 2016 Jun 07; 133(23):2222-34. PMID: 27081116.
    Citations: 39     Fields:    Translation:Humans
  49. Brooks GC, Lee BK, Rao R, Lin F, Morin DP, Zweibel SL, Buxton AE, Pletcher MJ, Vittinghoff E, Olgin JE. Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction: The PREDICTS Study. J Am Coll Cardiol. 2016 Mar 15; 67(10):1186-1196. PMID: 26965540.
    Citations: 18     Fields:    Translation:Humans
  50. Madhavan M, Waks JW, Friedman PA, Kramer DB, Buxton AE, Noseworthy PA, Mehta RA, Hodge DO, Higgins AY, Webster TL, Witt CM, Cha YM, Gersh BJ. Outcomes After Implantable Cardioverter-Defibrillator Generator Replacement for Primary Prevention of Sudden Cardiac Death. Circ Arrhythm Electrophysiol. 2016 Mar; 9(3):e003283. PMID: 26921377.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  51. Serber ER, Fava JL, Christon LM, Buxton AE, Goldberger JJ, Gold MR, Rodrigue JR, Frisch MB. Positive Psychotherapy to Improve Autonomic Function and Mood in ICD Patients (PAM-ICD): Rationale and Design of an RCT Currently Underway. Pacing Clin Electrophysiol. 2016 May; 39(5):458-70. PMID: 26813033.
    Citations: 2     Fields:    Translation:Humans
  52. Levine YC, Matos J, Rosenberg MA, Manning WJ, Josephson ME, Buxton AE. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy. Heart Rhythm. 2016 Feb; 13(2):490-7. PMID: 26409099.
    Citations: 9     Fields:    Translation:Humans
  53. Shvilkin A, Ellis ER, Gervino EV, Litvak AD, Buxton AE, Josephson ME. Painful left bundle branch block syndrome: Clinical and electrocardiographic features and further directions for evaluation and treatment. Heart Rhythm. 2016 Jan; 13(1):226-32. PMID: 26331973.
    Citations: 10     Fields:    Translation:Humans
  54. Huang HD, Waks JW, Contreras-Valdes FM, Haffajee C, Buxton AE, Josephson ME. Incidence and risk factors for symptomatic heart failure after catheter ablation of atrial fibrillation and atrial flutter. Europace. 2016 Apr; 18(4):521-30. PMID: 26311563.
    Citations: 6     Fields:    Translation:Humans
  55. Sciammarella MG, Gerson M, Buxton AE, Bartley SC, Doukky R, Merlino DA, Tandon S, Thompson R, Travin MI. ASNC/SNMMI Model Coverage Policy: Myocardial sympathetic innervation imaging: Iodine-123 meta-iodobenzylguanidine ((123)I-mIBG). J Nucl Cardiol. 2015 Aug; 22(4):804-11. PMID: 26163203.
    Citations: 5     Fields:    Translation:Humans
  56. Tschabrunn CM, Roujol S, Nezafat R, Faulkner-Jones B, Buxton AE, Josephson ME, Anter E. A swine model of infarct-related reentrant ventricular tachycardia: Electroanatomic, magnetic resonance, and histopathological characterization. Heart Rhythm. 2016 Jan; 13(1):262-73. PMID: 26226214.
    Citations: 37     Fields:    Translation:HumansAnimals
  57. Katritsis DG, Marine JE, Latchamsetty R, Zografos T, Tanawuttiwat T, Sheldon SH, Buxton AE, Calkins H, Morady F, Josephson ME. Coexistent Types of Atrioventricular Nodal Re-Entrant Tachycardia: Implications for the Tachycardia Circuit. Circ Arrhythm Electrophysiol. 2015 Oct; 8(5):1189-93. PMID: 26155802.
    Citations: 4     Fields:    Translation:Humans
  58. Kramer DB, Matlock DD, Buxton AE, Goldstein NE, Goodwin C, Green AR, Kirkpatrick JN, Knoepke C, Lampert R, Mueller PS, Reynolds MR, Spertus JA, Stevenson LW, Mitchell SL. Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium. Circ Cardiovasc Qual Outcomes. 2015 Jul; 8(4):437-46. PMID: 26038525.
    Citations: 10     Fields:    Translation:Humans
  59. Contreras-Valdes FM, Buxton AE, Josephson ME, Anter E. Atrial fibrillation ablation in patients with hypertrophic cardiomyopathy: long-term outcomes and clinical predictors. J Am Coll Cardiol. 2015 Apr 14; 65(14):1485-7. PMID: 25857916.
    Citations: 5     Fields:    Translation:Humans
  60. Tschabrunn CM, Silverstein J, Berzin T, Ellis E, Buxton AE, Josephson ME, Anter E. Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015 Jun; 17(6):891-7. PMID: 25777771.
    Citations: 12     Fields:    Translation:HumansAnimalsCTClinical Trials
  61. Levine YC, Tuttle MK, Rosenberg MA, Goldberg R, Matos J, Samuel M, Kramer DB, Buxton AE. Prevalence and outcomes of patients receiving implantable cardioverter-defibrillators for primary prevention not based on guidelines. Am J Cardiol. 2015 Jun 01; 115(11):1539-44. PMID: 25840578.
    Citations:    Fields:    Translation:HumansPHPublic Health
  62. Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton A, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders G. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2):179-86. PMID: 25669833.
    Citations: 22     Fields:    Translation:HumansPHPublic Health
  63. Waks JW, Higgins AY, Mittleman MA, Buxton AE. Influence of renal function on mortality and ventricular arrhythmias in patients undergoing first implantable cardioverter-defibrillator generator replacement. J Cardiovasc Electrophysiol. 2015 Mar; 26(3):282-90. PMID: 25431143.
    Citations: 3     Fields:    Translation:Humans
  64. Buxton AE, Wilde AA, Chen PS. A new ECG section in HeartRhythm by Josephson and Wellens. Heart Rhythm. 2014 Dec; 11(12):2328. PMID: 25454059.
    Citations:    
  65. Steinberg BA, Al-Khatib SM, Edwards R, Han J, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Inoue LY, Sanders GD. Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials. JACC Heart Fail. 2014 Dec; 2(6):623-9. PMID: 25306452.
    Citations: 17     Fields:    Translation:HumansPHPublic Health
  66. Anter E, Silverstein J, Tschabrunn CM, Shvilkin A, Haffajee CI, Zimetbaum PJ, Buxton AE, Josephson ME, Gelfand E, Manning WJ. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 2014 Nov; 11(11):1890-7. PMID: 25034183.
    Citations: 16     Fields:    Translation:Humans
  67. Levine YC, Rosenberg MA, Mittleman M, Samuel M, Methachittiphan N, Link M, Josephson ME, Buxton AE. B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias. Heart Rhythm. 2014 Jul; 11(7):1109-16. PMID: 24837348.
    Citations: 18     Fields:    Translation:Humans
  68. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Warner Stevenson L, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm. 2014 Jul; 11(7):1271-303. PMID: 24819194.
    Citations: 3     Fields:    Translation:Humans
  69. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014 Jul 01; 130(1):94-125. PMID: 24815500.
    Citations: 28     Fields:    Translation:Humans
  70. Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR, Hohnloser SH, Indik J, Lee R, Mehra MR, Menon V, Page RL, Shen WK, Slotwiner DJ, Stevenson LW, Varosy PD, Welikovitch L. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014 Sep 16; 64(11):1143-77. PMID: 24820349.
    Citations: 23     Fields:    Translation:Humans
  71. Wellens HJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH, Huikuri HV, Kääb S, La Rovere MT, Malik M, Myerburg RJ, Simoons ML, Swedberg K, Tijssen J, Voors AA, Wilde AA. Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J. 2014 Jul 01; 35(25):1642-51. PMID: 24801071.
    Citations: 93     Fields:    Translation:Humans
  72. Warraich HJ, Buxton AE, Kociol RD. Macroscopic T-wave alternans in a patient with takotsubo cardiomyopathy and QT prolongation. Heart Rhythm. 2014 Oct; 11(10):1848-9. PMID: 24607719.
    Citations: 2     Fields:    Translation:Humans
  73. Anter E, Tschabrunn CM, Contreras-Valdes FM, Buxton AE, Josephson ME. Radiofrequency ablation annotation algorithm reduces the incidence of linear gaps and reconnection after pulmonary vein isolation. Heart Rhythm. 2014 May; 11(5):783-90. PMID: 24583098.
    Citations: 11     Fields:    Translation:Humans
  74. Hoang A, Shen C, Zheng J, Taylor S, Groh WJ, Rosenman M, Buxton AE, Chen PS. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm. 2014 May; 11(5):849-55. PMID: 24566233.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  75. Pun PH, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Hess PL, Inoue LY, Sanders GD. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis. 2014 Jul; 64(1):32-9. PMID: 24518128.
    Citations: 38     Fields:    Translation:HumansPHPublic Health
  76. Kramer DB, Kennedy KF, Spertus JA, Normand SL, Noseworthy PA, Buxton AE, Josephson ME, Zimetbaum PJ, Mitchell SL, Reynolds MR. Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR. Heart Rhythm. 2014 Feb; 11(2):216-21. PMID: 24513917.
    Citations: 15     Fields:    Translation:Humans
  77. Goldberger JJ, Basu A, Boineau R, Buxton AE, Cain ME, Canty JM, Chen PS, Chugh SS, Costantini O, Exner DV, Kadish AH, Lee B, Lloyd-Jones D, Moss AJ, Myerburg RJ, Olgin JE, Passman R, Stevenson WG, Tomaselli GF, Zareba W, Zipes DP, Zoloth L. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014 Jan 28; 129(4):516-26. PMID: 24470473.
    Citations: 48     Fields:    Translation:Humans
  78. Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, Buxton AE, Cappato R, Dorian P, Hallstrom A, Kadish AH, Kudenchuk PJ, Lee KL, Mark DB, Moss AJ, Steinman R, Inoue LY, Sanders GD. Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator? Int J Cardiol. 2014 Mar 01; 172(1):253-4. PMID: 24467982.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  79. Buxton AE. Programmed ventricular stimulation: not dead. Circulation. 2014 Feb 25; 129(8):831-3. PMID: 24381210.
    Citations: 6     Fields:    Translation:Humans
  80. Rosenberg MA, Lopez FL, Bužková P, Adabag S, Chen LY, Sotoodehnia N, Kronmal RA, Siscovick DS, Alonso A, Buxton A, Folsom AR, Mukamal KJ. Height and risk of sudden cardiac death: the Atherosclerosis Risk in Communities and Cardiovascular Health studies. Ann Epidemiol. 2014 Mar; 24(3):174-179.e2. PMID: 24360853.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  81. Shen C, Jeong J, Li X, Chen PS, Buxton A. Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect. Biometrics. 2013 Sep; 69(3):724-31. PMID: 23865447.
    Citations: 1     Fields:    Translation:Humans
  82. Goldberger JJ, Buxton AE. Personalized medicine vs guideline-based medicine. JAMA. 2013 Jun 26; 309(24):2559-60. PMID: 23712449.
    Citations: 26     Fields:    Translation:Humans
  83. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, Spertus JA, Zimetbaum PJ, Reynolds MR, Mitchell SL. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes. 2013 Jul; 6(4):488-97. PMID: 23759471.
    Citations: 27     Fields:    Translation:Humans
  84. Fein AS, Shvilkin A, Shah D, Haffajee CI, Das S, Kumar K, Kramer DB, Zimetbaum PJ, Buxton AE, Josephson ME, Anter E. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013 Jul 23; 62(4):300-5. PMID: 23623910.
    Citations: 85     Fields:    Translation:Humans
  85. Rayatzadeh H, Tan A, Chan RH, Patel SJ, Hauser TH, Ngo L, Shaw JL, Hong SN, Zimetbaum P, Buxton AE, Josephson ME, Manning WJ, Nezafat R. Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy. J Cardiovasc Magn Reson. 2013 Apr 10; 15:31. PMID: 23574733.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  86. Hess PL, Laird A, Edwards R, Bardy GH, Bigger JT, Buxton AE, Moss AJ, Lee KL, Hall WJ, Steinman R, Dorian P, Hallstrom A, Cappato R, Kadish AH, Kudenchuk PJ, Mark DB, Al-Khatib SM, Piccini JP, Inoue LY, Sanders GD. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm. 2013 Jun; 10(6):828-35. PMID: 23416381.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  87. Rayatzadeh H, Patel SJ, Hauser TH, Ngo LL, Shaw JL, Tan A, Buxton AE, Zimetbaum P, Josephson ME, Appelbaum E, Manning WJ, Nezafat R. Volumetric left ventricular ejection fraction is superior to 2-dimensional echocardiography for risk stratification of patients for primary prevention implantable cardioverter-defibrillator implantation. Am J Cardiol. 2013 Apr 15; 111(8):1175-9. PMID: 23375599.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  88. Buxton AE. Implantable cardioverter-defibrillators for primary prevention of sudden death: the quest to identify patients most likely to benefit. J Am Coll Cardiol. 2012 Oct 23; 60(17):1656-8. PMID: 23021332.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  89. Anter E, Buxton AE, Silverstein JR, Josephson ME. Idiopathic ventricular fibrillation originating from the moderator b